Lexicon Pharmaceuticals Inc (LXRX)
1.545
-0.06
(-3.44%)
USD |
NASDAQ |
Apr 25, 16:00
1.55
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Cash from Investing (TTM): -49.94M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -49.94M |
| September 30, 2023 | -77.67M |
| June 30, 2023 | -115.54M |
| March 31, 2023 | -54.58M |
| December 31, 2022 | -71.08M |
| September 30, 2022 | -89.16M |
| June 30, 2022 | -12.36M |
| March 31, 2022 | 15.43M |
| December 31, 2021 | 2.11M |
| September 30, 2021 | 40.12M |
| June 30, 2021 | 256.32M |
| March 31, 2021 | 320.25M |
| December 31, 2020 | 380.76M |
| September 30, 2020 | 227.26M |
| June 30, 2020 | -19.83M |
| March 31, 2020 | -105.35M |
| December 31, 2019 | -155.86M |
| September 30, 2019 | 12.29M |
| June 30, 2019 | 99.97M |
| March 31, 2019 | 154.79M |
| December 31, 2018 | 169.58M |
| September 30, 2018 | -24.94M |
| June 30, 2018 | 5.711M |
| March 31, 2018 | 15.13M |
| December 31, 2017 | 50.52M |
| Date | Value |
|---|---|
| September 30, 2017 | 242.75M |
| June 30, 2017 | 189.60M |
| March 31, 2017 | 194.35M |
| December 31, 2016 | 18.25M |
| September 30, 2016 | -162.34M |
| June 30, 2016 | -118.47M |
| March 31, 2016 | -179.67M |
| December 31, 2015 | -117.02M |
| September 30, 2015 | -163.60M |
| June 30, 2015 | -220.86M |
| March 31, 2015 | -219.98M |
| December 31, 2014 | -108.42M |
| September 30, 2014 | 102.07M |
| June 30, 2014 | 101.80M |
| March 31, 2014 | 111.00M |
| December 31, 2013 | 99.54M |
| September 30, 2013 | 53.04M |
| June 30, 2013 | 44.45M |
| March 31, 2013 | 60.88M |
| December 31, 2012 | -97.81M |
| September 30, 2012 | -73.05M |
| June 30, 2012 | -53.95M |
| March 31, 2012 | -54.30M |
| December 31, 2011 | 69.96M |
| September 30, 2011 | -93.18M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-155.86M
Minimum
Dec 2019
380.76M
Maximum
Dec 2020
31.74M
Average
-12.36M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
| Novavax Inc | -58.81M |
| AIM ImmunoTech Inc | -0.832M |
| Perspective Therapeutics Inc | 24.37M |
| Protalix BioTherapeutics Inc | -16.71M |
| Armata Pharmaceuticals Inc | -8.134M |